These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36112315)

  • 1. Oncological safety of active surveillance for low-risk ductal carcinoma in situ - a systematic review and meta-analysis.
    Davey MG; Lowery AJ; Kerin MJ
    Ir J Med Sci; 2023 Aug; 192(4):1595-1600. PubMed ID: 36112315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal Carcinoma In Situ - Quo Vadis?
    Peltecu G
    Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes of Conservative Treatment for Low-Risk Ductal Carcinoma in Situ: A Systematic Review and Pooled Analysis.
    Co M; Cheng KCK; Yeung YH; Lau KC; Qian Z; Wong CM; Wong BY; Sin ELK; Wong HYS; Ma CH
    Clin Oncol (R Coll Radiol); 2023 Apr; 35(4):255-261. PubMed ID: 36764879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?
    Oseni TO; Smith BL; Lehman CD; Vijapura CA; Pinnamaneni N; Bahl M
    Ann Surg Oncol; 2020 Oct; 27(11):4459-4465. PubMed ID: 32418079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).
    Hwang ES; Hyslop T; Lynch T; Frank E; Pinto D; Basila D; Collyar D; Bennett A; Kaplan C; Rosenberg S; Thompson A; Weiss A; Partridge A
    BMJ Open; 2019 Mar; 9(3):e026797. PubMed ID: 30862637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
    Grimm LJ; Ghate SV; Hwang ES; Soo MS
    Acad Radiol; 2017 Nov; 24(11):1364-1371. PubMed ID: 28705686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012.
    van Maaren MC; Lagendijk M; Tilanus-Linthorst MMA; de Munck L; Pijnappel RM; Schmidt MK; Wesseling J; Koppert LB; Siesling S
    Eur J Cancer; 2018 Sep; 101():134-142. PubMed ID: 30059817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis.
    Davey MG; O'Flaherty C; Cleere EF; Nohilly A; Phelan J; Ronane E; Lowery AJ; Kerin MJ
    BJS Open; 2022 Mar; 6(2):. PubMed ID: 35380620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.
    Sagara Y; Mallory MA; Wong S; Aydogan F; DeSantis S; Barry WT; Golshan M
    JAMA Surg; 2015 Aug; 150(8):739-45. PubMed ID: 26039049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Survival Outcomes of 'Low Risk' Ductal Carcinoma in situ from a Territory-wide Cancer Registry.
    Co M; Ngan RKC; Mang OWK; Tam AHP; Wong KH; Kwong A
    Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):40-45. PubMed ID: 32713775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast.
    Van Bockstal MR; Agahozo MC; Koppert LB; van Deurzen CHM
    Int J Cancer; 2020 Mar; 146(5):1189-1197. PubMed ID: 31018242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
    Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
    JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Survival Comparison of Repeated Breast-conserving Surgery Versus Mastectomy for Patients with DCIS with Ipsilateral Breast Tumor Recurrence: A Real-world Longitudinal Study.
    Li Q; Wang K; Yang L; Wu Q; Zhu W; Li Z; Shi Y; Zhang X; Li H
    Clin Breast Cancer; 2021 Aug; 21(4):360-372. PubMed ID: 33846099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer.
    Ward WH; DeMora L; Handorf E; Sigurdson ER; Ross EA; Daly JM; Aggon AA; Bleicher RJ
    Ann Surg Oncol; 2020 Feb; 27(2):386-396. PubMed ID: 31562602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active surveillance of women diagnosed with atypical ductal hyperplasia on core needle biopsy may spare many women potentially unnecessary surgery, but at the risk of undertreatment for a minority: 10-year surgical outcomes of 114 consecutive cases from a single center.
    Farshid G; Edwards S; Kollias J; Gill PG
    Mod Pathol; 2018 Mar; 31(3):395-405. PubMed ID: 29099502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery.
    Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG
    Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients.
    Latronico A; Nicosia L; Faggian A; Abbate F; Penco S; Bozzini A; Cannataci C; Mazzarol G; Cassano E
    Breast; 2018 Feb; 37():1-5. PubMed ID: 29032282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.
    Grimm LJ; Ryser MD; Partridge AH; Thompson AM; Thomas JS; Wesseling J; Hwang ES
    Ann Surg Oncol; 2017 Nov; 24(12):3534-3540. PubMed ID: 28795370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.